AVENUE THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Avenue Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2022.
  • Avenue Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.08M, a 685% decline year-over-year.
  • Avenue Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.55M, a 4.8% increase from 2021.
  • Avenue Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.73M, a 27.6% increase from 2020.
  • Avenue Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$5.15M, a 80.1% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$3.55M +$179K +4.8% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 -$3.73M +$1.42M +27.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$5.15M +$20.8M +80.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 -$25.9M -$4.36M -20.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$21.5M -$9.29M -75.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$12.3M -$9.08M -286% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$3.18M +$2.05M +39.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 -$5.23M Feb 9, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.